Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -5.08% | +3.70% |
2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
Sales 2018 | 28.67M 39.34M | Sales 2019 | 32.63M 44.78M | Capitalization | 27.28M 37.43M |
---|---|---|---|---|---|
Net income 2018 | -16M -21.95M | Net income 2019 | -35M -48.02M | EV / Sales 2018 | 5.13 x |
Net Debt 2018 | 25.92M 35.57M | Net Debt 2019 | 33.9M 46.52M | EV / Sales 2019 | 1.87 x |
P/E ratio 2018 |
-7.1
x | P/E ratio 2019 |
-0.68
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 86.23% |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+3.70% | 27.65M | |
+5.73% | 71.48B | |
+11.94% | 9.18B | |
-15.34% | 4.79B | |
+34.54% | 3.98B | |
+5.09% | 3.97B | |
+27.76% | 2.56B | |
-28.33% | 2.29B | |
-24.15% | 2.23B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- CORV Stock